Screener
Spyre Therapeutics, Inc. SYRE Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001636282-26-000050
FAQ
- What is Spyre Therapeutics, Inc.'s book value per share?
- Spyre Therapeutics, Inc. (SYRE) reported book value per share of $8.54 in Q1 2026.
- How has Spyre Therapeutics, Inc.'s book value per share changed year-over-year?
- Spyre Therapeutics, Inc.'s book value per share increased by 6.6% year-over-year, from $8.01 to $8.54.
- What is the long-term trend for Spyre Therapeutics, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Spyre Therapeutics, Inc.'s book value per share has grown at a 33.6% compound annual growth rate (CAGR), from $2.62 to $11.17.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Spyre Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude